Objective Macrophage activation syndrome (MAS), a subtype of secondary haemophagocytic lymphohistiocytosis (HLH), is a rare ...
ELA026 demonstrated 100% overall response rate, improved survival, and a favorable safety profile in malignancy-associated HLH (mHLH), the most common type of sHLH with the poorest prognosis. Company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback